Purchases and Sales Made in Q1 2023 in Eucrates Biomedical Acquisition Corp. (EUCRW)
This table provides information about the institutional ownership of Eucrates Biomedical Acquisition Corp. (EUCRW) during Q1 2023. The information is specifically focused on institutions that hold shares of Eucrates Biomedical Acquisition Corp..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 09, 2023
Q1 2023
|
Cowen And Company, LLC
|
BUY
|
- |
80.1K+ 65.53% |
$2.4K - $10.4K
|
202K
$0
|
|
May 11, 2023
Q1 2023
|
K2 Principal Fund, L.P.
Toronto, A6 |
BUY
|
- |
34.5KNew |
$1.04K - $4.49K
|
34.5K
$0
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
18.2KNew |
$545 - $2.36K
|
18.2K
$0
|
|
May 12, 2023
Q1 2023
|
Clear Street LLC
|
BUY
|
- |
2.64KNew |
$79.1 - $343
|
2.64K
$0
|
|
May 12, 2023
Q1 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
215New |
$6.45 - $28
|
215
$0
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
May 15, 2023
Q1 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-380- 1.4% |
$11.4 - $49.4
|
26.8K
$0
|
|
May 16, 2023
Q1 2023
|
Cvi Holdings, LLC
Wilmington, DE |
SELL
|
- |
-43.2K- 58.35% |
$1.3K - $5.62K
|
30.9K
$0
|